July 22, 2026 — Penumbra, Inc. recently announced the results of Thunder, an Investigational Device Exemption (IDE) study, to evaluate the safety and effectiveness of Thunderbolt, the company's novel ...
Cath Lab
The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).
-
-
June 25, 2026 — Johnson & Johnson has announced the initiation of its Skyward investigational device exemption (IDE) clinical program evaluating the novel Shockwave SkyRunner Carotid Intravascular ...
-
June 13, 2026 — New research shows that infrainguinal endovascular interventions for peripheral artery disease (PAD) account for the largest cost of vascular surgeries paid within the Department of ...
-
June 11, 2026— Penumbra, Inc. has received U.S. Food and Drug Administration (FDA) clearance for Thunderbolt, expanding its computer assisted vacuum thrombectomy (CAVT) technology to address acute ...
July 22, 2026 — Penumbra, Inc. recently announced the results of Thunder, an Investigational Device Exemption (IDE) ...
July 27, 2026
July 21, 2026 — ElectroWire Medical recently announced that the U.S. Food and Drug Administration (FDA) has granted 510 ...
July 23, 2026
July 16, 2026 — Imperative Care has introduced the Ikon 24 Pro Guidewire, a neurovascular guidewire purpose-built to ...
July 17, 2026Sponsored Content
Feature | Thrombectomy Devices
Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...
June 01, 2026
July 9, 2026 — Elucid recently announced first patient enrollment in AI-Predict, a retrospective, international ...
July 13, 2026
July 7, 2026 — W. L. Gore & Associates’ medical business recently announced that the U.S. Food and Drug Administration ...
July 13, 2026
July 9, 2026 — On July 9, Stereotaxis announced that it has completed its previously announced acquisition of Robocath ...
July 10, 2026Sponsored Content
Blog | Contrast Media Injectors
Adjustable parameters on the ACIST® CVI® Contrast Delivery System include, flow rate, volume, pressure limit, rise time ...
August 22, 2023
July 8, 2026 — Johnson & Johnson has announced that the U.S. Food and Drug Administration (FDA) approved the Dual Energy ...
July 08, 2026
June 30, 2026 — Penumbra Inc. has received the CE Mark for Red 72 Silver Label and Red 72 Silver Label with SENDit ...
July 02, 2026
June 25, 2026 — Johnson & Johnson has announced the initiation of its Skyward investigational device exemption (IDE) ...
June 25, 2026Sponsored Content
Blog | Enterprise Imaging
As medical advancements continue to push the boundaries of what is possible in the field of structural heart ...
August 10, 2023
June 18, 2026 — Nyra Medical has been selected as the recipient of the 2026 Jon DeHaan Foundation Award for ...
June 19, 2026
June 18, 2026 — Allegheny Health Network's (AHN) Allegheny General Hospital (AGH) has completed a $19 million renovation ...
June 18, 2026
June 13, 2026 — New research shows that infrainguinal endovascular interventions for peripheral artery disease (PAD) ...
June 15, 2026Sponsored Content
Case Study | Baylor Scott and White Heart Hospital
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
May 05, 2023
June 15, 2006 — Penumbra, Inc. has secured the CE Mark in Europe for Thunderbolt, further laying the groundwork for ...
June 15, 2026
June 12, 2026 — Medtronic plc recently announced it has completed its acquisition of Scientia Vascular, a privately-held ...
June 12, 2026
June 11, 2026— Penumbra, Inc. has received U.S. Food and Drug Administration (FDA) clearance for Thunderbolt, expanding ...
June 12, 2026